APA (7th ed.) Citation

S, S., EE, C., S, S., AP, S., K, K., MB, B., . . . SV, A. (2014). Elucidation of the structural basis of interaction of the BCR-ABL kinase inhibitor, nilotinib (Tasigna) with the human ABC drug transporter P-glycoprotein. Leukemia, 28(4), 961. https://doi.org/10.1038/leu.2014.21

Chicago Style (17th ed.) Citation

S, Shukla, et al. "Elucidation of the Structural Basis of Interaction of the BCR-ABL Kinase Inhibitor, Nilotinib (Tasigna) with the Human ABC Drug Transporter P-glycoprotein." Leukemia 28, no. 4 (2014): 961. https://doi.org/10.1038/leu.2014.21.

MLA (9th ed.) Citation

S, Shukla, et al. "Elucidation of the Structural Basis of Interaction of the BCR-ABL Kinase Inhibitor, Nilotinib (Tasigna) with the Human ABC Drug Transporter P-glycoprotein." Leukemia, vol. 28, no. 4, 2014, p. 961, https://doi.org/10.1038/leu.2014.21.